Showing results (311-320 of 462) with videos related to
Sort By:
Pageof 47
Plos One|July 23, 2014
ZNF367 inhibits cancer progression and is targeted by miR-195Meenu Jain, Lisa Zhang, Myriem Boufraqech, et al.Clinical Endocrinology|July 5, 2018
The effect of lithium on the progression-free and overall survival in patients with metastatic differentiated thyroid cancer undergoing radioactive iodine therapyHongxiu Luo, Andrew Tobey, Sungyoung Auh, et al.Journal of the American College of Surgeons|July 25, 2015
Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1Samira M Sadowski, Corina Millo, Candice Cottle-Delisle, et al.Plos One|February 26, 2016
Increased Pleiotrophin Concentrations in Papillary Thyroid CancerYoun Hee Jee, Samira M Sadowski, Francesco S Celi, et al.Annals of Surgery|August 25, 2022
Adverse Cardiovascular Outcomes Among Older Adults With Primary Hyperparathyroidism Treated With Parathyroidectomy Versus Nonoperative ManagementCarolyn D Seib, Tong Meng, Robin M Cisco, et al.Mini Reviews in Medicinal Chemistry|September 28, 2013
Targeting heat shock protein 90 for malariaAnup S Ramdhave, Dhaval Patel, I Ramya, et al.Radiology|October 10, 2018
Cumulative Radiation Exposures from CT Screening and Surveillance Strategies for von Hippel-Lindau-associated Solid Pancreatic TumorsAmit Tirosh, Neige Journy, Les R Folio, et al.Frontiers in Endocrinology|July 30, 2021
Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort StudyKshama Aswath, James Welch, Sriram Gubbi, et al.JAMA Network Open|February 2, 2019
Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid CancerJoanna Klubo-Gwiezdzinska, Sungyoung Auh, Marvin Gershengorn, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 3, 2015
CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDYHana Turkova, Tamara Prodanov, Marek Maly, et al.Pageof 47